Blood urea nitrogen level may predict readmissions, mortality in HFpEF patients: Study Jacinthlyn Sylvia15 Sept 2022 7:30 PM ISTJapan: In a new study published in the International Journal of Cardiology, it was found that regardless of the renal function, blood urea nitrogen...
New Drug Molecule poyendarone developed for Treatment of Atrial Fibrillation Dr. Kamal Kant Kohli15 Sept 2022 12:00 PM ISTAF is a serious condition that can lead to heart failure, early mortality and stroke. For AF patients, there are currently medications which are used...
Empagliflozin proves beneficial in acute myocardial infarction: EMMY trial Dr. Kamal Kant Kohli11 Sept 2022 7:30 PM ISTAUSTRIA: Acute myocardial infarction (MI) patients who receive the SGLT2 inhibitor empagliflozin (Jardiance) early after the MI have improved markers...
SGLT2 inhibitors foundational therapy in all HF patients regardless of EF: Pooled analysis of DAPA-HF and DELIVER Dr. Kamal Kant Kohli9 Sept 2022 8:00 PM ISTPrevious studies have shown that the SGLT2 inhibitor dapagliflozin reduces cardiovascular mortality and morbidity in patients with diabetes, chronic...
SGLT2 inhibitors useful for HF patients with mildly reduced and preserved ejection fraction: Deliver Trial Dr. Kamal Kant Kohli7 Sept 2022 11:00 AM ISTPrevious studies have shown that the SGLT2 inhibitor dapagliflozin reduces cardiovascular mortality and morbidity in patients with diabetes, chronic...
AstraZeneca Forxiga gets Chinese nod to treat CKD with and without type 2 diabetes Ruchika Sharma6 Sept 2022 11:15 AM ISTForxiga (dapagliflozin) is a first-in-class, oral, once-daily SGLT2 inhibitor.
Medical Bulletin 1/September/2022 Isra Zaman1 Sept 2022 3:51 PM ISTHere are the top medical news for the day:Addiction management may help treat heart infection in drug addictsAddiction management may help treat heart...
Link between low physical function and future cardiovascular diseases in elderly Isra Zaman1 Sept 2022 9:15 AM ISTAmong people older than age 65 who were assessed using a short physical function test, having lower physical function was independently associated...
Medical Bulletin 30/August/2022 Isra Zaman30 Aug 2022 5:30 PM ISTHere are the top medical news for the day:Lower heart failure risk by boosting physical activityA six-year analysis of more than 94,000 adults in the...
Replace ACE inhibitors with sacubitril/valsartan once symptomatic HF develops in MI: insight from Paradise MI Dr. Kamal Kant Kohli30 Aug 2022 11:00 AM ISTPost hoc analysis of Paradise MI Trial has provided new insights on sacubitril/valsartan in myocardial infarction in a session in a Hot Line session...
Boosting physical activity may reduce risk of heart failure Isra Zaman30 Aug 2022 9:00 AM ISTA six-year analysis of more than 94,000 adults in the U.K. Biobank with no history of heart failure at enrollment has found that engaging in moderate...
Sacubitril, valsartan combo safe for HFpEF, not likely to cause cognitive decline Dr. Kamal Kant Kohli29 Aug 2022 10:30 AM ISTAccording to a new study, administration of combination of sacubitril/valsartan (Entresto) for heart failure with moderately reduced or preserved left...
